Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system

Molecular Therapy

Volumn 6, Issue 2, 2002, Pages 219-226

  Kaneda, Yasufumi ^a   Nakajima, Toshihiro ^b   Nishikawa, Tomoyuki ^a   Yamamoto, Seiji ^a   Ikegami, Hiroyuki ^a   Suzuki, Naho ^b   Nakamura, Hitomi ^a   Morishita, Ryuichi ^a   Kotani, Hitoshi ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Anges MG Inc   (Japan)

Author keywords

Drug delivery; Gene therapy; Gene transfer; HVJ envelope; Targeting

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; LUCIFERASE; OLIGODEOXYNUCLEOTIDE DERIVATIVE; PLASMID DNA; PROTAMINE SULFATE; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; BRAIN; CANCER CELL CULTURE; CELL LINE; CENTRIFUGATION; CONTROLLED STUDY; EYE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; IN VIVO STUDY; LIPID MEMBRANE; LIVER; LUNG; NONHUMAN; PARAINFLUENZA VIRUS 1; REPORTER GENE; SKIN; SPLEEN; UTERUS; VIRAL GENE DELIVERY SYSTEM; VIRUS ENVELOPE; VIRUS INACTIVATION; VIRUS PARTICLE;

ANIMALIA; HUMAN PARAINFLUENZA VIRUS 1; SENDAI VIRUS;

EID: 0036664449     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2002.0647     Document Type: Article

References (45)

1. Marshall, E. (1995). Gene therapy's growing pains. Science 269: 1052-1055.
2. Ledley, F. D. (1995). Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum. Gene Ther. 6: 1129-1144.
3. Mulligan, R. C. (1993). The basic science of gene therapy. Science 260: 926-932.
4. Morral, N., et al. (1999). Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc. Natl. Acad. Sci. USA 96: 12816-12821.
5. Zou, L., Zhou, H., Pastore, L., and Yang, K. (2000). Prolonged transgene expression mediated by a helper-dependent adenoviral vector (hdAd) in the central nervous system. Mol. Ther. 2: 105-13.
6. Legendre, J. Y., and Szoka, F. C., Jr. (1992). Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes. Pharm. Res. 9: 1235-1242.
7. Wheeler, C. J., et al. (1996). A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc. Natl. Acad. Sci. USA 93: 11454-11459.
8. Russell, D. W., and Miller, A. D. (1996). Foamy virus vectors. J. Virol. 70: 217-222.
9. Condreay, J. P., Witherspoon, S. M., Clay, W. C., and Kost, T. A. (1999). Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc. Natl. Acad. Sci. USA 96: 127-132.
10. Strayer, D. S. (1999). Gene therapy using SV40-derived vectors: what does the future hold? J. Cell Physiol. 181: 375-384.
11. Gebhart, C. L., Kabanov, A. V. (2001). Evaluation of polyplexes as gene transfer agents. J. Control Release. 73: 401-416.
12. Burns, J. C., Friedmann, T., Driever, W., Burrascano, M., and Yee, J. K. (1993). Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90: 8033-8037.
13. Naldini, L., et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentivirus vector. Science 272: 263-267.
14. Li, S., and Huang, L. (1997). In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther. 4: 891-900.
15. Li, S., Rizzo, M. A., Bhattacharya, S., and Huang, L. (1998). Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther. 5: 930-937.
16. Kaneda, Y., Iwai, K., and Uchida, T. (1989). Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 243: 375-378.
17. Kato, K., Nakanishi, M., Kaneda, Y., Uchida, T., and Okada, Y. (1991). Expression of hepatitis B virus surface antigen in adult rat liver. J. Biol. Chem. 266: 3361-3364.
18. Tsuboniwa, N., et al. (2001). Safety evaluation of HVJ-AVE liposomes in nonhuman primates. Hum. Gene Ther. 12: 469-487.
19. Dzau, V. J., Mann, M., Morishita, R., and Kaneda, Y. (1996). Fusigenic viral liposome for gene therapy in cardiovascular diseases. Proc. Natl. Acad. Sci. USA 93: 11421-11425.
20. Kaneda, Y., Saeki, Y., and Morishita, R. (1999). Gene therapy using HVJ-liposomes: the best of both worlds? Mol. Med. Today 5: 298-303.
21. Uchida, T., Kim., J., Yamaizumi, M., Miyake, Y., and Okada, Y. (1979). Reconstitution of lipid vesicles associated with HVJ (Sendai virus) spikes. Purification and some properties of vesicles containing nontoxic fragment A of diphtheria toxin. J. Cell Biol. 80: 10-20.
22. Suzuki, K., et al. (2000). Reconstituted fusion liposomes for gene transfer in vitro and in vivo. Gene Ther. Regulat. 1: 65-77.
23. Bagai, S., and Sarkar, D. P. (1993). Targeted delivery of hygromycin B using reconstituted Sendai viral envelopes lacking hemagglutinin-neuraminidase. FEBS Lett. 326: 183-188.
24. Ramani, K., Bora, R. S., Kumar, M., Tyagi, S. K., and Sarkar, D. P. (1997). Novel gene delivery to liver cells using engineered virosomes. FEBS Lett. 404: 164-168.
25. Ramani, K., Hassan, O., Venkaiah, B., Hasnain, S. E., and Sarkar, D. P. (1998). Site-specific gene delivery in vivo through engineered Sendai virus envelopes. Proc. Natl. Acad. Sci. USA 95: 11886-11890.
26. Nakanishi, M., Uchida, T., and Okada, Y. (1982). Glycoproteins of Sendai virus (HVJ) have a critical ratio for fusion between virus envelopes and cell membranes. Exp. Cell Res. 142: 95-101.
27. Okada, Y. (1993). Sendai virus-induced cell fusion. Methods Enzymol. 221: 18-41.
28. Myers, T. M., Smallwood, S., and Moyer, S. A. (1999). Identification of nucleocapsid protein residues required for Sendai virus nucleocapsid formation and genome replication. J. Gen. Virol. 80: 1383-1391.
29. Swaney, W. P., Sorgi, F. L., Bahnson, A. B., and Barranger, J. A. (1997). The effect of cationic liposome pretreatment and centrifugation on retrovirus-mediated gene transfer. Gene Ther. 4: 1379-1386.
30. Cornetta, K., and Anderson, F. (1989). Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene transfer: implications for human gene therapy. J. Virol. Methods 23: 187-194.
31. Clark, P. R., et al. (1999). Polycations and cationic lipids enhance adenovirus transduction and transgene expression in tumor cells. Cancer Gene Ther. 6: 437-446.
32. Lanuti, M., et al. (1999). Use of protamine to augment adenovirus-mediated cancer gene therapy. Gene Ther. 6: 1600-1610.
33. Yang, Y.W., and Hsieh, Y.C. (2001). Protamine sulfate enhances the transduction efficiency of recombinant adeno-associated virus-mediated gene delivery. Pharm. Res. 18: 922-927.
34. Sorgi, F. L., Bhattacharya, S., and Huang, L. (1997). Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther. 4: 961-968.
35. Allen, T. M., Williamson, P., and Schlegel, R. A. (1988). Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome model of the erythrocyte surface. Proc. Natl. Acad. Sci. USA 85: 8067-8071.
36. Zhou, W. Z., et al. (1999). RNA melanoma vaccine; induction of anti-tumor immunity by human gp100 mRNA immunization. Hum. Gene Ther. 10: 2719-2724.
37. Calos, M. P. (1996). The potential of extrachromosomal replicating vectors for gene therapy. Trends Genet. 12: 463-466.
38. Saeki, Y., Wataya-Kaneda M., Tanaka, K., and Kaneda, Y. (1998). Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ-liposomes. Gene Ther. 5: 1031-1037.
39. Kaneda, Y. (1994). Virus (Sendai virus envelopes) mediated gene transfer. In Cell Biology: A Laboratory Handbook Vol. 3 (J.E. Celis, Ed.), pp. 50-57. Academic Press, Orlando, FL.
40. Race, E., et al. (1995). A multistep procedure for the chemical inactivation of human immunodeficiency virus for use as an experimental vaccine. Vaccine 13: 1567-1575.
41. Inaba, K., et al. (1992). Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
42. Kaneda, Y., Uchida, T., Ishiura, M., Kim, J., and Okada, Y. (1987). The improved efficient method for introducing macromolecules into cells using HVJ (Sendai virus) liposomes with gangliosides. Exp. Cell Res. 173: 56-69.
43. de Martin, R., Raidi, M., Hofer, E., and Binder, B. R. (1997). Adenovirus-mediated expression of green fluorescent protein. Gene Ther. 5: 493-495.
44. Saeki, Y., et al. (1997). Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer. Hum. Gene Ther. 8: 1965-1972.
45. Guttenberger, M. (1998). Protein determination. In Cell Biology: A Laboratory Handbook, 2nd edition, Vol. 4 (J. E. Celis, Ed.), pp. 295-303. Academic Press, Orlando, FL.